-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2017 to 2021.
- LogicBio Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was -$7K, a 95.4% increase year-over-year.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$840K, a 105% decline from 2020.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $17M.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$18.5M, a 3096% decline from 2018.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)